Bio-Rad Laboratories Inc. - Class B - Price History
Stock symbol BIO.B is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for BIO.B (Bio-Rad Laboratories Inc. - Class B)
| Date | Adjusted price | Real price |
|---|---|---|
| May 2024 | $317.26 | $317.26 |
| June 2023 | $371.10 | $371.10 |
| May 2023 | $373.90 | $373.90 |
| April 2023 | $464.10 | $464.10 |
| March 2023 | $464.10 | $464.10 |
| February 2023 | $404.66 | $404.66 |
| January 2023 | $404.66 | $404.66 |
| December 2022 | $404.66 | $404.66 |
| November 2022 | $404.66 | $404.66 |
| October 2022 | $518.95 | $518.95 |
| September 2022 | $518.95 | $518.95 |
| August 2022 | $518.95 | $518.95 |
| July 2022 | $484.36 | $484.36 |
| June 2022 | $471.62 | $471.62 |
| May 2022 | $505 | $505 |
| April 2022 | $507.99 | $507.99 |
| March 2022 | $587.56 | $587.56 |
| February 2022 | $645.69 | $645.69 |
| January 2022 | $569.50 | $569.50 |
| December 2021 | $347.25 | $347.25 |
| November 2021 | $347.25 | $347.25 |
| October 2021 | $347.25 | $347.25 |
| September 2021 | $347.25 | $347.25 |
| August 2021 | $347.25 | $347.25 |
| July 2021 | $347.25 | $347.25 |
| June 2021 | $347.25 | $347.25 |
| May 2021 | $347.25 | $347.25 |
| April 2021 | $347.25 | $347.25 |
| March 2021 | $347.25 | $347.25 |
| February 2021 | $597.60 | $597.60 |
| January 2021 | $574.15 | $574.15 |
| December 2020 | $574 | $574 |
| November 2020 | $603.78 | $603.78 |
| October 2020 | $530 | $530 |
| September 2020 | $480.20 | $480.20 |
| August 2020 | $502.45 | $502.45 |
| July 2020 | $484.41 | $484.41 |
| June 2020 | $447.75 | $447.75 |
| May 2020 | $466.33 | $466.33 |
| April 2020 | $434 | $434 |
| March 2020 | $333.70 | $333.70 |
| February 2020 | $347.25 | $347.25 |
| January 2020 | $292.60 | $292.60 |
| December 2019 | $292.60 | $292.60 |
| November 2019 | $292.60 | $292.60 |
| October 2019 | $292.60 | $292.60 |
BIO.B
Price: $317.26
52 week price:
Earnings Per Share: 118.29 USD
P/E Ratio: 5.04
Sector: Healthcare
Industry: Medical Devices
Volume: 13
Market Capitalization: 23.2 billion